Sepracor withdraws EMEA application for insomnia drug

Sepracor Pharmaceuticals Ltd, a subsidiary of Sepracor Inc of Marlborough, Mass., has withdrawn its marketing authorisation application for an insomnia drug from the EMEA because the regulator refused to recognise it as a new active substance.